Search

1201004
1195994
393884
209802
1197163
Community Engagement
In March 2016 SATVI brought "Lienkie se Longe", a drama to raise awareness about TB, to the Worcester Easter Festival. The drama tells the story of Lienkie, whose lungs “talk with each other’ about their health and the health of Lienkie’s boyfriend...
Biomarker discovery offers hope for new TB vaccine development
A team of scientists from the University of Cape Town, Oxford University and the London School of Hygiene & Tropical Medicine have made a discovery that reveals how we can improve development of more effective vaccines against tuberculosis.
Community Engagement
In 2012 SATVI developed a drama production to promote awareness about TB vaccine clinical research, titled “Carina’s Choice” with learners from Worcester Secondary School as actors and UCT drama school students as mentors. A very successful roadshow...
Accredited UCT Research Centre
The South African Tuberculosis Vaccine Initiative (SATVI) is an accreditated Research Centre of the University of Cape Town.
Kick TB Schools Program 17- 27 May 2016
On Tuesday 17 May 2016, SATVI kicked off a districtwide TB awareness raising program, in partnership with TB Alliance, the Western Cape Education Department, AERAS, TB Care (USAID), in Robertson.

News

Friday, 23 June 2017
12 May 2017 International Nurses Day

On Friday 12 May 2017, the South African Tuberculosis Vaccine Initiative paid homage to the many nurses in the Cape Winelands District with the donation of cupcakes to brighten up their teatime.

Publication Date:
Friday, May 12, 2017 - 14:30
5 May 2017 Research Published A Functional TOLLIP Variant is Associated with BCG-Specific Immune Responses and Tuberculosis.

SATVI authors Professor Mark Hatherill, Associate Professor Tom Scriba & Dr  Munyaradzi Musvosvi have published an article titled "A Functional TOLLIP Variant is Associated with BCG-Specific Immune Responses and Tuberculosis" appearing in the  American Journal of Respiratory and Critical Care Medicine.

Publication Date:
Friday, May 5, 2017 - 21:15
21 April 2017 Research Mortality in Severe HIV-TB Associates with Innate Immune Activation and Dysfunction of Monocytes.

SATVI author Dr Elisa Nemes has co-authored a paper titled "Mortality in Severe HIV-TB Associates with Innate Immune Activation and Dysfunction of Monocytes" appearing in the Clinical Infectious Diseases Journal.

Publication Date:
Friday, April 21, 2017 - 08:15
19 April 2017 Research: The CSF immune response in HIV-1-associated cryptococcal meningitis: macrophage activation, correlates of disease severity and effect of antiretroviral therapy.

SATVI author Associate Professor Tom Scriba has co-authored a paper titled "The CSF immune response in HIV-1-associated cryptococcal meningitis: macrophage activation, correlates of disease severity and effect of antiretroviral therapy" appearing in the Journal of Acquired Immune Deficiency Syndromes.

Publication Date:
Wednesday, April 19, 2017 - 10:00

Pages